AP NEWS

Explainable Artificial Intelligence for Drug Discovery & Development, 2018 - ResearchAndMarkets.com

September 27, 2018

DUBLIN--(BUSINESS WIRE)--Sep 27, 2018--The “Explainable Artificial Intelligence for Drug Discovery and Development” report has been added to ResearchAndMarkets.com’s offering.

This report encompasses recent advances in artificial intelligence platforms enabling drug discovery and development, while highlighting the importance of explainability in AI-driven technologies for healthcare. The report also provides an overview of the AI value chain.

Key Topics Covered

1. Recent Advances in Artificial Intelligence for Drug Discovery

Employing Artificial Intelligence for Drug Discovery Explainable Artificial Intelligence Solutions AI-based Drug Discovery Innovation Scouting Explainable AI Drug Discovery: Approaches and Features

2. Clinical Trial Analysis and Key Contacts

Kyndi’s Explainable AI Platform Key Contacts

For more information about this report visit https://www.researchandmarkets.com/research/37g9kg/explainable?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180927005362/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drug Discovery

KEYWORD:

INDUSTRY KEYWORD: HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/27/2018 05:51 AM/DISC: 09/27/2018 05:50 AM

http://www.businesswire.com/news/home/20180927005362/en

AP RADIO
Update hourly